SEI Trust Company’s Novartis NVS Stock Holding History

SEI Trust Company’s Portfolio NVS Stock Details NVS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2014 Q3	$27.2M	Sell	322,325 -11,010	-3%	-$891K	0.26%	86
2014 Q2	$27M	Buy	333,335 +5,699	+2%	+$448K	0.26%	88
2014 Q1	$25M	Sell	327,636 -12,723	-4%	-$927K	0.25%	96
2013 Q4	$24.5M	Sell	340,359 -3,511	-1%	-$244K	0.23%	106
2013 Q3	$23.6M	Buy	343,870 +3,740	+1%	+$247K	0.26%	96
2013 Q2	$21.6M	Buy	+340,130	New	+$22.1M	0.26%	103

Other funds holding NVS

Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

BBHC

Brown Brothers Harriman & Co New York $18.6B AUM 15.81% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

BTS

BB&T Securities Richmond, Virginia $10.9B AUM 5.31% 1-Year Est. Return

Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return

UBS Zurich, Switzerland $136B AUM 16.36% 1-Year Est. Return

MAA

Managed Account Advisors Jersey City, New Jersey $121B AUM 7.32% 1-Year Est. Return

Loomis, Sayles & Company Boston, Massachusetts $74.3B AUM 24.01% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

SEI Trust Company's NVS Position: Q3 2014 in Review

SEI Trust Company reduced its Novartis (NVS) stake by 3.3% in Q3 2014, selling an estimated $891K and leaving 322,325 shares worth $27.2M. The position accounts for 0.26% of the portfolio, ranked #86.

SEI Trust Company first reported a position in NVS in Q2 2013 and has held it in 6 quarters since. 875 funds tracked by Wall St. Rank hold NVS as of Q3 2014.

SEI Trust Company held 322,325 shares of Novartis worth $27.2M as of Q3 2014.
SEI Trust Company sold 11,010 Novartis shares in Q3 2014, an estimated $891K.
Novartis made up 0.26% of SEI Trust Company's portfolio in Q3 2014, its #86 holding.
SEI Trust Company first reported a position in Novartis in Q2 2013 and has held it in 6 quarters since.
875 funds tracked by Wall St. Rank held Novartis as of Q3 2014.

Based on SEI Trust Company's 13F filing for Q3 2014, filed 28 Oct 2014.